Cargando…
HBV DNA suppression during entecavir treatment in previously treated children with chronic hepatitis B
The aim of this study was to assess HBV DNA suppression after 24 weeks of treatment with entecavir in previously treated children with CHB. Thirty children aged 5–17 years (25 males and 5 females) with CHB were treated with entecavir 0.5 or 1 mg daily. Twenty-two children were HBeAg-positive, eight...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303069/ https://www.ncbi.nlm.nih.gov/pubmed/21796345 http://dx.doi.org/10.1007/s10096-011-1349-0 |